rxstat › Classes › Insulins And Analogues

Insulins And Analogues: shortage status in Canada

1 of the 14 insulins and analogues rxstat tracks is currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Partial shortageInsulin Glargine1 of 6 reported products affected · est. return Jul 31, 2026 No current shortageInsulin No current shortageInsulin Aspart DiscontinuedInsulin Detemir0 of 2 reported products affected No current shortageInsulin Glulisine No current shortageInsulin Injection Human Biosynthetic DiscontinuedInsulin Injection Pork0 of 1 reported products affected DiscontinuedInsulin Isophane Human Biosynthetic0 of 1 reported products affected DiscontinuedInsulin Isophane Human Biosynthetic Insulin Injection Human Biosynthetic0 of 3 reported products affected DiscontinuedInsulin Isophane Injection Pork0 of 1 reported products affected DiscontinuedInsulin Isophane Insulin0 of 1 reported products affected No current shortageInsulin Lispro DiscontinuedInsulin Nph Human Dna Origin0 of 1 reported products affected DiscontinuedInsulin Semi Synthetic Human0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.